205 related articles for article (PubMed ID: 32602377)
1. Synthesis,
Sağlık BN; Osmaniye D; Acar Çevik U; Levent S; Kaya Çavuşoğlu B; Atlı Eklioğlu Ö; Özkay Y; Koparal AS; Kaplancıklı ZA
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1422-1432. PubMed ID: 32602377
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, monoamine oxidase inhibition and docking studies of new dithiocarbamate derivatives bearing benzylamine moiety.
Kaya Çavuşoğlu B; Sağlık BN; Özkay Y; İnci B; Kaplancıklı ZA
Bioorg Chem; 2018 Feb; 76():177-187. PubMed ID: 29175589
[TBL] [Abstract][Full Text] [Related]
3. Discovery of novel and potent safinamide-based derivatives as highly selective hMAO-B inhibitors for treatment of Parkinson's disease (PD): Design, synthesis, in vitro, in vivo and in silico biological studies.
Elkamhawy A; Paik S; Park JH; Kim HJ; Hassan AHE; Lee K; Park KD; Roh EJ
Bioorg Chem; 2021 Oct; 115():105233. PubMed ID: 34390968
[TBL] [Abstract][Full Text] [Related]
4. Design and Synthesis of New Benzothiazole Compounds as Selective hMAO-B Inhibitors.
Ilgın S; Osmaniye D; Levent S; Sağlık BN; Acar Çevik U; Çavuşoğlu BK; Özkay Y; Kaplancıklı ZA
Molecules; 2017 Dec; 22(12):. PubMed ID: 29232838
[TBL] [Abstract][Full Text] [Related]
5. Biphenylpiperazine Based MAO Inhibitors: Synthesis, Biological Evaluation, Reversibility and Molecular Modeling Studies.
El-Halaby LO; El-Husseiny WM; El-Messery SM; Goda FE
Bioorg Chem; 2021 Oct; 115():105216. PubMed ID: 34352710
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of some novel hydrazone and 2-pyrazoline derivatives: monoamine oxidase inhibitory activities and docking studies.
Evranos-Aksöz B; Yabanoğlu-Çiftçi S; Uçar G; Yelekçi K; Ertan R
Bioorg Med Chem Lett; 2014 Aug; 24(15):3278-84. PubMed ID: 24986657
[TBL] [Abstract][Full Text] [Related]
7. MAO enzymes inhibitory activity of new benzimidazole derivatives including hydrazone and propargyl side chains.
Can ÖD; Osmaniye D; Demir Özkay Ü; Sağlık BN; Levent S; Ilgın S; Baysal M; Özkay Y; Kaplancıklı ZA
Eur J Med Chem; 2017 May; 131():92-106. PubMed ID: 28301816
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of New Hydrazone Derivatives for MAO Enzymes Inhibitory Activity.
Can NÖ; Osmaniye D; Levent S; Sağlık BN; İnci B; Ilgın S; Özkay Y; Kaplancıklı ZA
Molecules; 2017 Aug; 22(8):. PubMed ID: 28825649
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, in vitro and in silico evaluation of new pyrrole derivatives as monoamine oxidase inhibitors.
Altintop MD; Sever B; Osmaniye D; Sağlık BN; Özdemir A
Arch Pharm (Weinheim); 2018 Jul; 351(7):e1800082. PubMed ID: 29963739
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, molecular modelling and biological activity of some pyridazinone derivatives as selective human monoamine oxidase-B inhibitors.
Özdemir Z; Alagöz MA; Uslu H; Karakurt A; Erikci A; Ucar G; Uysal M
Pharmacol Rep; 2020 Jun; 72(3):692-704. PubMed ID: 32144745
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, and evaluation of 1, 4-benzodioxan-substituted chalcones as selective and reversible inhibitors of human monoamine oxidase B.
Kong Z; Sun D; Jiang Y; Hu Y
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1513-1523. PubMed ID: 32705910
[TBL] [Abstract][Full Text] [Related]
12. 2-Heteroarylidene-1-indanone derivatives as inhibitors of monoamine oxidase.
Nel MS; Petzer A; Petzer JP; Legoabe LJ
Bioorg Chem; 2016 Dec; 69():20-28. PubMed ID: 27662218
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, in vitro, and in silico studies of 1,2,4-triazole-piperazine hybrid derivatives as potential MAO inhibitors.
Uslu H; Osmaniye D; Sağlik BN; Levent S; Özkay Y; Benkli K; Kaplancikli ZA
Bioorg Chem; 2021 Dec; 117():105430. PubMed ID: 34678603
[TBL] [Abstract][Full Text] [Related]
14. Discovery of 3,4-dichloro-N-(1H-indol-5-yl)benzamide: A highly potent, selective, and competitive hMAO-B inhibitor with high BBB permeability profile and neuroprotective action.
Elkamhawy A; Kim HJ; Elsherbeny MH; Paik S; Park JH; Gotina L; Abdellattif MH; Gouda NA; Cho J; Lee K; Nim Pae A; Park KD; Roh EJ
Bioorg Chem; 2021 Nov; 116():105352. PubMed ID: 34562673
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of new hydrazone derivatives and evaluation of their monoamine oxidase inhibitory activity.
Tok F; Sağlık BN; Özkay Y; Ilgın S; Kaplancıklı ZA; Koçyiğit-Kaymakçıoğlu B
Bioorg Chem; 2021 Sep; 114():105038. PubMed ID: 34102520
[TBL] [Abstract][Full Text] [Related]
16. Semicarbazones, thiosemicarbazone, thiazole and oxazole analogues as monoamine oxidase inhibitors: Synthesis, characterization, biological evaluation, molecular docking, and kinetic studies.
Qazi SU; Naz A; Hameed A; Osra FA; Jalil S; Iqbal J; Shah SAA; Mirza AZ
Bioorg Chem; 2021 Oct; 115():105209. PubMed ID: 34364054
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and biological assessment of new thiazolylhydrazine derivatives as selective and reversible hMAO-A inhibitors.
Can NÖ; Osmaniye D; Levent S; Sağlık BN; Korkut B; Atlı Ö; Özkay Y; Kaplancıklı ZA
Eur J Med Chem; 2018 Jan; 144():68-81. PubMed ID: 29248751
[TBL] [Abstract][Full Text] [Related]
18. Halogenated class of oximes as a new class of monoamine oxidase-B inhibitors for the treatment of Parkinson's disease: Synthesis, biochemistry, and molecular dynamics study.
Thomas Parambi DG; Oh JM; Kumar S; Sudevan ST; Hendawy OM; Abdelgawad MA; Musa A; Al-Sanea MM; Ahmad I; Patel H; Kim H; Mathew B
Comput Biol Chem; 2023 Aug; 105():107899. PubMed ID: 37315342
[TBL] [Abstract][Full Text] [Related]
19. Novel Thiosemicarbazone Derivatives: In Vitro and In Silico Evaluation as Potential MAO-B Inhibitors.
Osmaniye D; Kurban B; Sağlık BN; Levent S; Özkay Y; Kaplancıklı ZA
Molecules; 2021 Nov; 26(21):. PubMed ID: 34771054
[TBL] [Abstract][Full Text] [Related]
20. New coumarin derivatives: design, synthesis and use as inhibitors of hMAO.
He X; Chen YY; Shi JB; Tang WJ; Pan ZX; Dong ZQ; Song BA; Li J; Liu XH
Bioorg Med Chem; 2014 Jul; 22(14):3732-8. PubMed ID: 24856304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
